Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03977454 · ClinicalTrials.gov registry record · Phase 2
Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 192
- Enrollment target
NCT03977454 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 192 participants.
The verdict
NCT03977454, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 192 participants
- Enrollment target
Study Summary
This study will assess if preoperative quadratus lumborum block (QLB)/lateral femoral cutaneous nerve block (LFCNB) with ropivacaine and glucocorticoids provide more effective analgesia than periarticular injection (PAI) with the same mixture in total hip arthroplasty (THA).
Interventions
- DRUG Ropivacaine
- PROCEDURE Nerve Block
- PROCEDURE Periarticular Injection (PAI)
- DRUG Dex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2019-11-11 |
| Est. Completion | 2021-06-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03977454
The ClinicalTrials.gov registry entry for NCT03977454 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ropivacaine is the first listed.
NCT03977454 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03977454 about?
NCT03977454 is a clinical study titled "Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty". This study will assess if preoperative quadratus lumborum block (QLB)/lateral femoral cutaneous nerve block (LFCNB) with ropivacaine and glucocorticoids provide more effective analgesia than periarticular injection (PAI) with the same mixture in total hip arthroplasty (THA).
What is the current status of trial NCT03977454?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 192 participants. The study started on 2019-11-11. Estimated completion is 2021-06-19.
What interventions are being tested in trial NCT03977454?
The interventions under investigation include: Ropivacaine (DRUG), Nerve Block (PROCEDURE), Periarticular Injection (PAI) (PROCEDURE), Dex (DRUG).
Who is sponsoring clinical trial NCT03977454?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.